Literature DB >> 15036559

Optic nerve crush: protection and regeneration.

Michal Schwartz1.   

Abstract

In neurodegenerative disorders, as well as in acute central nervous system (CNS) injuries, the initial impairment triggers a cascade of destructive events, collectively termed secondary degeneration, which eventually cause much more extensive damage. To investigate the process of secondary degeneration and ways to prevent it, we designed a well-calibrated model of optic nerve crush injury. Until recently, the main purpose of the immune system was thought to be protection of the body against alien pathogens. Since mechanical or biochemical insults do not involve exogenous pathogens, recruitment of the adaptive immune system was not considered relevant in such cases. We recently demonstrated, however, that a T-cell-mediated immune response directed against self-antigens residing in the site of damage can be beneficial for the injured optic nerve or spinal cord. This protective autoimmune response was found to be spontaneously evoked in some individuals, but not strongly enough to significantly affect recovery. Our aim was to boost this protective response in those individuals capable of spontaneously manifesting it, and to induce it in those incapable of manifesting it spontaneously. Optimal functional recovery requires the application of a proper combination of neuroprotection and neuroregeneration.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15036559     DOI: 10.1016/S0361-9230(03)00076-5

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  19 in total

1.  Diffusion tensor imaging detects retinal ganglion cell axon damage in the mouse model of optic nerve crush.

Authors:  Xu Zhang; Peng Sun; Jian Wang; Qing Wang; Sheng-Kwei Song
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-09-01       Impact factor: 4.799

2.  Regulatory T cells in CNS injury: the simple, the complex and the confused.

Authors:  James T Walsh; Jonathan Kipnis
Journal:  Trends Mol Med       Date:  2011-07-07       Impact factor: 11.951

3.  Sema-3A indirectly disrupts the regeneration process of goldfish optic nerve after controlled injury.

Authors:  Shira Rosenzweig; Dorit Raz-Prag; Anat Nitzan; Ronit Galron; Ma'ayan Paz; Gunnar Jeserich; Gera Neufeld; Ari Barzilai; Arieh S Solomon
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-05-07       Impact factor: 3.117

4.  Up-regulation of SKIP relates to retinal ganglion cells apoptosis after optic nerve crush in vivo.

Authors:  Yu Wu; Fan Xu; Hui Huang; Lifei Chen; Meidan Wen; Li Jiang; Lu Lu; Li Li; Di Song; Siming Zeng; Li Li; Min Li
Journal:  J Mol Histol       Date:  2014-07-30       Impact factor: 2.611

Review 5.  Sprouting, regeneration and circuit formation in the injured spinal cord: factors and activity.

Authors:  Irin C Maier; Martin E Schwab
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-09-29       Impact factor: 6.237

6.  Wnt signaling promotes axonal regeneration following optic nerve injury in the mouse.

Authors:  Amit K Patel; Kevin K Park; Abigail S Hackam
Journal:  Neuroscience       Date:  2016-12-21       Impact factor: 3.590

Review 7.  Rodent models of glaucoma.

Authors:  Thomas V Johnson; Stanislav I Tomarev
Journal:  Brain Res Bull       Date:  2009-04-18       Impact factor: 4.077

8.  A novel animal model of partial optic nerve transection established using an optic nerve quantitative amputator.

Authors:  Xu Wang; Ying Li; Yan He; Hong-Sheng Liang; En-Zhong Liu
Journal:  PLoS One       Date:  2012-09-04       Impact factor: 3.240

9.  Neuritin 1 promotes retinal ganglion cell survival and axonal regeneration following optic nerve crush.

Authors:  T P Sharma; Y Liu; R J Wordinger; I-H Pang; A F Clark
Journal:  Cell Death Dis       Date:  2015-02-26       Impact factor: 8.469

10.  Early cellular signaling responses to axonal injury.

Authors:  Thomas J Lukas; Ai Ling Wang; Ming Yuan; Arthur H Neufeld
Journal:  Cell Commun Signal       Date:  2009-03-13       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.